Status:
COMPLETED
Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea
Lead Sponsor:
Pfizer
Conditions:
Major Depression
Eligibility:
All Genders
18+ years
Brief Summary
The primary purpose of this study is to investigate medication utilization pattern and risk of adverse outcomes among commonly used antidepressants by using nationwide claims database, in order to ass...
Detailed Description
While there are many antidepressants from which physicians can select based on efficacy and tolerability profile, evidence on effectiveness and safety outcomes of new antidepressants in real clinical ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patients must meet all of the following inclusion criteria to be eligible for inclusion in the study:
- Patients aged 18 years or older on the index date
- Patients who had at least one inpatient claim or two outpatient claims in the intake period with any of the following diagnosis codes F06.3 Organic mood \[affective\] disorders F32\* Depressive episode F33\* Recurrent depressive disorder F34.1 Neurotic depression F38.1 Other recurrent mood \[affective\] disorder F41.2 Mixed anxiety and depressive disorder
- Patients prescribed any of the following antidepressant during intake period (from January 1, 2017 to June 30, 2018)
- Exclusion Criteria
- Patients meeting any of the following criteria will not be included in the study:
- Patients with a claim of diagnosis codes in Table 1 during the 12 month pre-index period
- Patients with a claim of prescription in Table 2 during the 12 month pre-index period
- Patient who had a claim as a beneficiary of Medical Aid program (Korean Medicaid program with free or minimum copay)
- Patients who are hospitalized at the index date
- Patients who are under hospice care (procedure codes WG\*-WO\*)
Exclusion
Key Trial Info
Start Date :
July 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 3 2022
Estimated Enrollment :
370212 Patients enrolled
Trial Details
Trial ID
NCT04446039
Start Date
July 4 2022
End Date
November 3 2022
Last Update
December 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer
Seoul, South Korea